By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Intra-Cellular Therapies, Inc. 

3960 Broadway

New York  New York  10032  U.S.A.
Phone: 212-923-3344 Fax: 212-923-3388


SEARCH JOBS


Industry
Biotechnology






Company News
Intra-Cellular Therapies, Inc. To Present At The 2015 RBC Capital Markets' Healthcare Conference 2/18/2015 8:10:30 AM
Intra-Cellular Therapies, Inc. To Present At The Leerink Global Healthcare Conference 2/3/2015 7:54:36 AM
Intra-Cellular Therapies, Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/12/2015 8:51:52 AM
Intra-Cellular Therapies, Inc. Announces Enrollment Of First Patient In Phase 3 Trial Of ITI-007 For The Treatment Of Schizophrenia 11/25/2014 9:49:31 AM
Intra-Cellular Therapies, Inc. Announces Additional Results From Phase I/2 Clinical Trial For ITI-007 In Healthy Geriatric Subjects And Patients With Dementia 11/21/2014 11:25:20 AM
Intra-Cellular Therapies, Inc. Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/3/2014 8:49:12 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Walks Away From Intra-Cellular Therapies, Inc. CNS Disorders Deal 11/3/2014 6:12:23 AM
Intra-Cellular Therapies, Inc. To Host Conference Call On Monday, November 3, At 8:30 Am Eastern Time, On Third Quarter 2014 Financial Results 10/27/2014 10:06:19 AM
Intra-Cellular Therapies, Inc.'s Dementia Drug Meets Phase 1/2 Goals 10/13/2014 6:33:20 AM
Intra-Cellular Therapies, Inc. To Present Results From Phase 1/2 Clinical Trial For ITI-007 In Healthy Geriatric Subjects And Patients With Dementia At The American Neurological Association 139th Annual Meeting 10/7/2014 7:24:39 AM
12345
//-->